BioBusiness

Although there are many differences between the industries, especially related to regulatory requirements, there are enough similarities that the future of biopharmaceuticals with respect to contract manufacturing might look much like the semiconductor industry.

The employer's first step in considering whether to use non-competition and non-disclosure agreements is to assess, analyze, and understand the benefits of such agreements.

According to a 2002 report by the consulting firm BioPerspectives, the protein biochip market will reach $700 million in sales by 2006.

Commercial embodiments of genetically modified inventions are protected in Canada.

Regional Roundup: Georgia

Regional Round-Up: Florida

The Madrid Protocol offers companies another option for trademark registration on a global scale.

Carefully prosecuted patent applications lead to patents with valid and enforceable claims that provide broad coverage for your technology.

Scotland's life sciences community lost an icon this past year with the death of Dolly the Sheep. Cloned by Roslin Institute in 1996, Dolly came to symbolize Scotland's world-leading innovation in the life sciences. However, biotechnology in Scotland goes beyond a cloned sheep.

Roslin Institute is one of the world's leading centers for research on farm and other animals. It has internationally recognized programs in molecular and quantitative genetics, genomics, early development, reproduction, and animal behavior and welfare, and it has pioneered methods for the genetic modification and cloning of farm animals. In recent years, the institute also initiated a major new program in human stem cell research.

Regional Round-Up: North Carolina

Quintiles Transnational is a global company, headquartered in North Carolina. It employs a global workforce of approximately 16,000 in more than 48 countries. The company helps improve healthcare worldwide by providing a broad range of professional services, information, and partnering solutions to the pharmaceutical, biotechnology, and healthcare industries.

Regional Round-Up: South Carolina

Research and preparation are key to obtaining and successfully conducting an interview.

Medicare Reform and Health Savings Accounts

In early November 2003, Wyeth BioPharma, headquartered in Andover, MA, hosted the quarterly meeting of the BioPharma Operations Excellence Consortium. Approximately 50 people representing over 15 companies attended this first meeting of the consortium's newly established East Coast chapter.

On March 25, 2004 Centocor will host the first meeting of the European chapter in Leiden, Holland. Wyeth BioPharma and Genzyme have co-sponsored the establishment of this European group; other leading companies - such as Lonza Biologics, Celltech, and Baxter Bioscience - have joined the forum.

Regional Roundup: Pennsylvania

Regional Round-Up: Virginia

Operational planning and early cost analyses are key to generating optimal, robust, and economical commercial processes.

Online resources for Canadian investment.

On Wall Street, accurately predicting the future is the Holy Grail. At the end of the day, the traders and investors who come closest to guessing what will happen one hour, one day, or one week down the road are the ones who go home winners.

Biotech patent decisions before the Supreme Court and the Prime Minister's commitment to innovation will shape the future of life sciences protection in Canada.

In September 2003, Sweden's biotechnology sector recorded a striking achievement. Amgen, the world's largest biotechnology company, announced plans to acquire exclusive rights to Biovitrum's small-molecule enzyme inhibitors for the treatment of metabolic diseases.

As the various industry sectors expand drug discovery and development activities, there will be more direct competition as well as opportunities for collaboration.

BioPharm International and Tefen Ltd. have teamed up to provide you with information and tools from the BioPharma Operations Excellence Consortium.

Biopharmaceutical manufacturers face many bioprocessing concerns including safety, flexibility, maintenance, capacity, capital investment, and process costs. Disposable products can reduce some of the burden.